Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
17.28
0.00 (0.00%)
Nov 21, 2024, 11:56 AM EST - Market open
Fulgent Genetics Market Cap
Fulgent Genetics has a market cap or net worth of $528.54 million as of November 21, 2024. Its market cap has decreased by -34.25% in one year.
Market Cap
528.54M
Enterprise Value
-280.36M
1-Year Change
-34.25%
Ranking
Category
Stock Price
$17.28
Market Cap Chart
Since September 29, 2016, Fulgent Genetics's market cap has increased from $156.50M to $528.54M, an increase of 237.73%. That is a compound annual growth rate of 16.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 520.00M | -39.30% |
| Dec 29, 2023 | 856.70M | -2.28% |
| Dec 30, 2022 | 876.70M | -70.78% |
| Dec 31, 2021 | 3.00B | 137.27% |
| Dec 31, 2020 | 1.26B | 423.90% |
| Dec 31, 2019 | 241.40M | 321.29% |
| Dec 31, 2018 | 57.30M | -26.63% |
| Dec 29, 2017 | 78.10M | -61.81% |
| Dec 30, 2016 | 204.50M | 30.67% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Astria Therapeutics | 516.94M |
| Mereo BioPharma Group | 515.81M |
| Silence Therapeutics | 515.71M |
| Opthea | 515.09M |
| Pharming Group | 511.58M |
| Altimmune | 508.54M |
| Savara | 507.99M |
| Talkspace | 505.08M |